Лекарственная терапия нейропатического болевого синдрома
- Авторы: Камчатнов П.Р1, Евзельман М.А2
-
Учреждения:
- ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России, Москва
- ФГБОУ ВПО Орловский государственный университет
- Выпуск: Том 16, № 2 (2014)
- Страницы: 10-13
- Раздел: Статьи
- URL: https://bakhtiniada.ru/2075-1753/article/view/93988
- ID: 93988
Цитировать
Полный текст
Аннотация
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
П. Р Камчатнов
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России, Москва
М. А Евзельман
ФГБОУ ВПО Орловский государственный университет
Список литературы
- Алексеев В.В., Яхно Н.Н. Боль. Болезни нервной системы. Руководство для врачей. Под ред. Н.Н.Яхно, Д.Р.Штульмана. М.: Медицина, 2001; 1: 106-24.
- Гусев Е.И., Камчатнов П.Р. Пластичность головного мозга в норме и патологии. Журн. невропатол. и психиатр. им. С.С.Корсакова. 2003; 11: 44-8.
- Кукушкин М.Л., Хитров Н.К. Общая патология боли. М.: Медицина, 2004.
- Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13 (11): 1153-69.
- Attal N, Cruccu G, Baron R et al. European Federation of Neurological Societies. Eur J Neurol 2010; 17 (9): 1113-88.
- Cardenas D, Nieshoff E, Suda K. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology 2013; 80 (6): 533-9.
- Devor M, Lomazov P, Matzner O. Sodium channel accumulation in injured axons as a substrate for neuropathic pain. Touch, temperature and pain in health and disease: mechanisms and assessments. Eds.: J.Boivie, P.Hansson, U.Lindblom. In: Progress in pain research and management series. Seattle: IASP Press 1994; 3: 207-30.
- Dworkin R, Corbin A, Young J et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo - controlled trial. Neurology 2003; 60 (8): 1274-83.
- Freynhagen R, Strojek K, Griesing T. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double - blind, multicentre, placebo - controlled trial of flexible - and fixed - dose regimens. Pain 2005; 115 (3): 254-63.
- Freynhagen R, Rolke R, Baron R et al. Pseudoradicular and radicular low - back pain - a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain 2008; 135 (1-2): 65-74.
- Hansson P, Fields H, Hill R, Marchettini P. Neuropathic pain: pathophysiology and treatment, progress in pain research and management. Seattle, WA: IASP Press 2001; 21: 151-67.
- Jacquy J, Lossignol D, Sternon J. Pregabalin (Lyrica) and neuropathic pain syndromes. Rev Med Brux 2006; 27 (5): 445-50.
- Kim J, Bashford G, Murphy T. Safety and efficacy of pregabalin in patients with central post - stroke pain. Pain 2011; 152 (5):1018-123.
- Korff M, Saunders K. The course of back pain in primary care. Spine 1996; 21: 2833-7.
- Kroenke K, Krebs E, Bair M. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiat 2009; 31 (3): 206-19.
- Li C, Zhang X, Matthews E et al. Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain 2006, 125: 20-34.
- Lopez-Trigo J, Sancho Rieger J. Pregabalin. A new treatment for neuropathic pain. Neurologia 2006; 21 (2): 96-103.
- Luo Z, Chaplan S, Higuera E et al. Upregulation of dorsal root ganglion alpha2delta calcium channel subunit and its correlation with allodynia in spinal nerve - injured rats. J Neurosci 2001; 21: 1868-75.
- LYRICA Study Group Pregabalin for peripheral neuropathic pain: results of a multicenter, non - comparative, open - label study in Indian patients. Int J Clin Pract 2006; 60 (9): 1060-7.
- Maizels M, Mccarberg B. Antidepressants and antiepileptic drugs for chronic non - cancer pain. J Am Ac Fam Physicians 2005; 71 (3): 188-92.
- Martinez J, Kasamatsu M, Rosales-Hernandez A et al. Comparison of central vs. peripheral delivery of pregabalin in neuropathic pain states. Molecular Pain 2012; 8 (1): 3. http://doi: 10.1186/1744-8069-8-3
- Matthews E, Dickenson A. Effects of spinally delivered N- and P- type voltage - dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001; 92: 235-46.
- Moore R, Straube S, Wiffen P et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009; 3: CD007076.
- O’Connor A, Dworkin R. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009; 122 (Suppl. 10): s22-32.
- Richter R, Portenoy R, Sharma U. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo - controlled trial. J Pain 2005; 6 (4): 253-60.
- Romanò C, Romanò D, Bonora C, Mineo G. Pregabalin, celecoxib,and their combination for treatment of chronic low - back pain. J Orthop Traumatol 2009; 10 (4): 185-91.
- Rosenstock J, Tuchman M, La Moreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double - blind, placebo - controlled trial. Pain 2004; 110 (3): 628-38.
- Sabatowski R, Galvez R, Cherry D.A. 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post - herpetic neuralgia: results of a randomised, placebo - controlled clinical trial. Pain 2004; 109 (1-2): 26-35.
- Siddall P, Cousins M, Otte A et al. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo - controlled trial. Neurology 2006; 67 (10): 1792-800.
- Tesfaye S, Boulton A, Dyck P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-93.
- Tesfaye S, Wilhelm S, Lledo A et al. Duloxetine and pregabalin: High - dose monotherapy or their combination? The COMBO-DN study - a multinational, randomized, double - blind, parallel - group study in patients with diabetic peripheral neuropathic pain. Pain 2013; 154 (12): 2616-25.
- Tremont-Lukats I, Megeff C, Backonja M. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 2000; 60 (5): 1029-52.
- Van Seventer R, Feister H, Young J et al. Efficacy and tolerability of twice - daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 2006; 22 (2): 375-84.
- Van Seventer R, Bach F, Toth C et al. Pregabalin in the treatment of post - traumatic peripheral neuropathic pain: a randomized double - blind trial. Eur J Neurol 2010; 17 (8): 1082-9.
- Vinik A, Casellini C. Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin. J Diabetes Met Syndrome Obesity: Targets Ther 2013; 6: 57-78.
- Waxman S, Cummins T, Dib-Hajj S et al. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve 1999; 22: 1177-87.
- White D, Zimmermann M. The bradykinin - induced release of substance P from nerve fibre endings in the rat saphenous nerve neuroma is not related to electrophysiological excitation. Neurosci Lett 1988; 92: 108-13.
- Wiffen P, Mc Quay H, Edwards J, Moore R. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005; 3: CD005452.
- Zhao Y, Sun P, Bernauer M. Comparing common reasons for inpatient and outpatient visits between commercially - insured duloxetine or pregabalin initiators with fibromyalgia. J Pain Research 2012; 5: 443-51.
- Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabet Met Res Rev 2008; 24 (Suppl. 1): s52-7.
- Carey T.S, Evans A.T, Hadler N.M et al. Acute severe low back pain. A population - based study of prevalence and care - seeking. Spine 1996; 21 (3): 339-44.
- Loney P.L, Stratford P.W. The prevalence of low back pain in adults: a methodological review of the literature. Phys Ther 1999; 79 (4): 384-96.
- Berger A, Dukes E.M, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004; 5 (3): 143-9.
- Данилов А.Б. Управление болью. М.: АММ Пресс, 2012.
Дополнительные файлы
